[{"address1": "680 East Colorado Boulevard", "address2": "Suite 180", "city": "Pasadena", "state": "CA", "zip": "91101", "country": "United States", "phone": "631 830 7092", "fax": "631 982 5050", "website": "https://lixte.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Lixte Biotechnology Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies. Its lead product candidate, LB-100 is in phase 1b clinical trials combined with Atezolizumab for patients with microsatellite stable metastatic colorectal cancer. The company's LB-100 combined with doxorubicin in advanced soft tissue sarcoma is under Phase 1b portion; and LB-100 combined with dostarlimab that is in phase 1b/2 for ovarian clear cell carcinoma. The company has a clinical trial research agreement with the Netherlands Cancer Institute; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group; and a development collaboration agreement with the Netherlands Cancer Institute. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Pasadena, California.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Mr. Peter M. Stazzone", "age": 71, "title": "Chief Financial Officer", "yearBorn": 1953, "exercisedValue": 0, "unexercisedValue": 0}], "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 5.42, "open": 5.4319, "dayLow": 5.1238, "dayHigh": 5.6, "regularMarketPreviousClose": 5.42, "regularMarketOpen": 5.4319, "regularMarketDayLow": 5.1238, "regularMarketDayHigh": 5.6, "payoutRatio": 0.0, "beta": 0.477, "volume": 118573, "regularMarketVolume": 118573, "averageVolume": 2113030, "averageVolume10days": 232580, "averageDailyVolume10Day": 232580, "bid": 5.24, "ask": 5.5, "bidSize": 1, "askSize": 10, "marketCap": 24859428, "fiftyTwoWeekLow": 0.64, "fiftyTwoWeekHigh": 6.26, "fiftyDayAverage": 4.312, "twoHundredDayAverage": 2.2926, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 23972216, "profitMargins": 0.0, "floatShares": 4267657, "sharesOutstanding": 4561363, "sharesShort": 21411, "sharesShortPriorMonth": 247724, "sharesShortPreviousMonthDate": 1753920000, "dateShortInterest": 1756425600, "sharesPercentSharesOut": 0.0047, "heldPercentInsiders": 0.108459994, "heldPercentInstitutions": 0.06336, "shortRatio": 0.16, "shortPercentOfFloat": 0.0047, "impliedSharesOutstanding": 4561363, "bookValue": 0.236, "priceToBook": 23.09322, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -3088952, "trailingEps": -1.28, "lastSplitFactor": "1:10", "lastSplitDate": 1685923200, "52WeekChange": 1.9619565, "SandP52WeekChange": 0.1653893, "quoteType": "EQUITY", "currentPrice": 5.45, "recommendationKey": "none", "totalCash": 887212, "totalCashPerShare": 0.195, "totalDebt": 0, "quickRatio": 1.652, "currentRatio": 1.843, "returnOnAssets": -0.99791, "returnOnEquity": -2.1320798, "freeCashflow": -1292541, "operatingCashflow": -2612238, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "LIXT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1758322122, "regularMarketTime": 1758312003, "shortName": "Lixte Biotechnology Holdings, I", "longName": "Lixte Biotechnology Holdings, Inc.", "exchange": "NCM", "messageBoardId": "finmb_29181356", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.553501, "regularMarketPrice": 5.45, "marketState": "CLOSED", "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1193319000000, "postMarketChangePercent": 0.0, "postMarketPrice": 5.45, "postMarketChange": 0.0, "regularMarketChange": 0.0299997, "regularMarketDayRange": "5.1238 - 5.6", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2113030, "fiftyTwoWeekLowChange": 4.81, "fiftyTwoWeekLowChangePercent": 7.515625, "fiftyTwoWeekRange": "0.64 - 6.26", "fiftyTwoWeekHighChange": -0.8100004, "fiftyTwoWeekHighChangePercent": -0.12939303, "fiftyTwoWeekChangePercent": 196.19565, "dividendDate": 1605830400, "earningsTimestampStart": 1754510400, "earningsTimestampEnd": 1754942400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.28, "fiftyDayAverageChange": 1.138, "fiftyDayAverageChangePercent": 0.26391467, "twoHundredDayAverageChange": 3.1574, "twoHundredDayAverageChangePercent": 1.3772136, "sourceInterval": 15, "displayName": "Lixte Biotechnology", "trailingPegRatio": null, "__fetch_time": "2025-09-20"}]